Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Srikant Datar
AddedMar 31, 2024
UpdatedMay 31, 2026
Srikant Datar

Srikant Datar

Board Member, T-Mobile (US)

Crunchbase

Srikant Datar's Career

T-Mobile (US)
T-Mobile (US)

Bellevue, WA, US

Board Member· Board
Novartis
Novartis

Basel, Basel-Stadt, CH

Board Member· Board
ICF
ICF

Fairfax, VA, US

Board Member· Board
Stryker
Stryker

Kalamazoo, MI, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Srikant Datar's Career

T-Mobile (US)
T-Mobile (US)
Public$9.7B75k2001Bellevue, WA, US
Board Member· Board

Recent news

T-Mobile Reinvents Business Internet from the Ground Up and the Sky Down with SuperBroadbandT-Mobile · 2026
Scribe hits $1.3B valuation as it moves to show where AI will actually pay offTechCrunch · 2025
Andrew Yang took inspiration from Mark Cuban for his budget cell carrier Noble MobileTechCrunch · 2025

Leadership at T-Mobile (US)

Mike SievertMike SievertCEO
Srini GopalanSrini GopalanPresident and CEO
Lawrence GuffeyLawrence GuffeyBoard Member
Raphael KüblerRaphael KüblerBoard Member
Teresa A TaylorTeresa A TaylorBoard Member
Marcelo ClaureMarcelo ClaureBoard Member
Novartis
Novartis
Public$6.5M101.7k2002Basel, Basel-Stadt, CH
Board Member· Board

Leadership at Novartis

Nancy AndrewsNancy AndrewsBoard Member
Ann Marie FudgeAnn Marie FudgeBoard Member
Enrico VanniEnrico VanniBoard Member
Joerg ReinhardtJoerg ReinhardtBoard Member
Vasant NarasimhanVasant NarasimhanCEO
Andreas Von PlantaAndreas Von PlantaBoard Member

Similar to Novartis

Novartis Institutes For Biomedical ResearchNovartis Institutes For Biomedical ResearchCambridge, MA, USDrug Discoveryest. 2002Novartis Institutes For Biomedical ResearchCambridge, MA, US · est. 2002

Novartis Institutes For Biomedical Research: A noncommercial research organization founded in 2002.

10k
Novartis PharmaNovartis PharmaTokyo, Tokyo, JPPharmaceuticalsest. 1997Novartis PharmaTokyo, Tokyo, JP · est. 1997

Tokyo-based Novartis Pharma, a key subsidiary of global healthcare leader Novartis Pharmaceuticals.

Public3k
Bristol Myers SquibbBristol Myers SquibbNew York City, NY, USPharmaceuticalsest. 1887Bristol Myers SquibbNew York City, NY, US · est. 1887

Leading American pharmaceutical company specializing in research and development.

Public · $10.6B34.3k
LonzaLonzaBasel, Basel-Stadt, CHBiotech, Pharmaceuticalsest. 1897LonzaBasel, Basel-Stadt, CH · est. 1897

Swiss-based Lonza, a global partner in pharmaceuticals, biotech, and nutrition, develops and commercializes medical treatments worldwide.

Public · $400M17.5k
ICF
ICF
Investment FirmInvestment Firm$59M11.2k1969Fairfax, VA, US
Board Member· Board

Leadership at ICF

John WassonJohn WassonBoard Member
John WassonJohn WassonBoard Member
Randall MehlRandall MehlBoard Member
Herbert WinokurHerbert WinokurCo-Founder
Stephen RitterbushStephen RitterbushFounder
Michael-Mike BelgraveMichael-Mike BelgraveBoard Member

Similar to ICF

ICFICFBarcelona, Barcelona Province, ESest. 1985ICFBarcelona, Barcelona Province, ES · est. 1985

ICF Capital, a public financial institution, fosters economic growth in Catalonia by providing funding and financial services to local companies.

Investment Firm147
International FinanceInternational FinanceWashington, D.C., DC, USest. 1956International FinanceWashington, D.C., DC, US · est. 1956

IFC: A World Bank Group member providing investment, advisory, and asset-management services for developing nations.

Investment Firm7.5k
Ic-UsaIc-UsaBaltimore, MD, USest. 1999Ic-UsaBaltimore, MD, US · est. 1999

IC-USA: A business consulting firm offering passive investment strategies for long-term growth.

Investment Firm · $9M30
Icahn PartnersIcahn PartnersSunny Isles Beach, FL, USest. 2004Icahn PartnersSunny Isles Beach, FL, US · est. 2004

Investment firm specializing in finance and investments.

Investment Firm50
Stryker
Stryker
Public51k1941Kalamazoo, MI, US
Board Member· Board

Leadership at Stryker

Kevin LoboKevin LoboBoard Member
Rajeev SuriRajeev SuriBoard Member
Lisa Skeete TatumLisa Skeete TatumBoard Member
Sheri McCoySheri McCoyBoard Member
Roch DoliveuxRoch DoliveuxBoard Member
Andrew SilvernailAndrew SilvernailBoard Member

Srikant Datar's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailJaeHong ChoiJaeHong ChoiBoard Member · KakaoMason YeoMason YeoBoard Member · Kakao

People Similar to Srikant Datar

Andrew LoAndrew LoBoard Member · Roivant SciencesDas NarayandasDas NarayandasBoard Member · Titan CompanyDouglas StaigerDouglas StaigerCo-Founder · ArborMetrixEric JanszenEric JanszenCo-Founder · iTulipDavid StasavageDavid StasavageBoard Member · New York UniversityKatherine BaickerKatherine BaickerBoard Member · Eli Lilly and Company